Mechanism study on the effect of androgen antagonism in prostate cancer
CONCLUSION: Under the action of 4-HNE, the expression of AR-MAPK pathway related proteins increase. 4-HNE may promote the progression of prostate cancer through the AR-MAPK pathway, and 4-HNE is expected to become a new therapeutic target for CRPC.PMID:38602755
Source: Cancer Control - Category: Cancer & Oncology Authors: Xu Song Qiang Song Rong Wang Qing-Jun Zuo Zhi-Yuan Zhang Source Type: research
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Genetics | Prostate Cancer | Statistics | Study